The Immune Response to SARS-CoV-2 and Variants of Concern
At the end of 2019 a newly emerged betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of severe pneumonia, subsequently termed COVID-19, in a number of patients in Wuhan, China. Subsequently, SARS-CoV-2 rapidly spread globally, r...
Main Authors: | Elham Torbati, Kurt L. Krause, James E. Ussher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/10/1911 |
Similar Items
-
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
by: Fuxing Lou, et al.
Published: (2021-11-01) -
SARS-CoV-2 Variants, Vaccines, and Host Immunity
by: Priyal Mistry, et al.
Published: (2022-01-01) -
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
by: Felipe Melo-González, et al.
Published: (2021-11-01) -
Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern
by: Jesse W. Wotring, et al.
Published: (2022-04-01) -
Immune targets to stop future SARS-CoV-2 variants
by: Milena Silva Souza, et al.
Published: (2023-12-01)